ABSTRACT OF THE WEEK

Journal of feline medicine and surgery
Volume 13 | Issue 10 (October 2011)

Safety and palatability of polyethylene glycol 3350 as an oral laxative in cats.

J Feline Med Surg. October 2011;13(10):694 - 697.

Fiona M Tam¹, Anthony P Carr, Sherry L Myers

¹ Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. fiona.tam@usask.ca

Abstract

Recurrent constipation is a common problem in cats. Laxatives often are the cornerstone for management of recurrent constipation; however, there is a paucity of published research on laxative use in cats. This study investigated the safety and palatability of polyethylene glycol (PEG3350) in normal cats. All cats consumed the PEG3350 laxative for 4 weeks without changes in weight or food intake. In all cats soft stools were achieved. Effective doses varied widely in experimental cats, so individualized dosing is important. Mild, non-clinical hyperkalemia was noted although the cause is unknown.

Companion Notes

Report on the safety and palatability of polyethylene glycol 3350 as an oral laxative in normal cats

Study design

- introduction on the treatment of constipation in cats

- laxatives commonly used as part of management

- polyethylene glycol (PEG3350) is a bulking and softening agent

- large molecular weight, water-soluble polymer

- in human medicine widely used as an osmotic laxative

- not metabolized by intestinal bacterial

- minimally absorbed

- each molecule hydrogen bonds with 100 molecules of water

- this results in high osmotic pressures in bowel lumen

- this acts against the absorption of water out of the lumen

- in multiple meta-analyses

- PEG3350 a more effective laxative than lactulose

- as well as many other oral laxatives

- adverse events are self-limiting and include the following:

- distended abdomen with pain

- nausea

- excessive diarrhea

- clinical hyponatremia not documented with daily low-dose use

- lactulose is a commonly used osmotic laxative

- in human medicine

- moderate evidence of efficacy and safety for chronic constipation

- in veterinary medicine: no evidence to support use

- soluble and insoluble dietary fibers

- in human medicine

- weak evidence of efficacy and safety for chronic constipation

- in feline medicine: no evidence to support use

- study population: 6 healthy cats from 1-4 years of age in a closed colony

- there was no history of diarrhea or constipation in the colony

- procedure:

- pilot trial on 2 of the cats to determine an effective initial dose

- treatment trial for 4 weeks

- PEG3350 with electrolytes (Colyte oral solution; Schwarz Pharma)

- 1.9 g per meal with the powder mixed with food

- cats were fed twice daily

(Iams, ProActive Adult formula, canned and dry)

- standard weight of canned and dry food offered each meal

- unconsumed amount weighed

- dosage titrated in each cat to achieve soft, formed stool (grade II-III)

- initial dose doubled if no effect seen within 48 hours

- assessment methods:

- fecal scores assessed daily; standardized fecal grading scale used

- grade I: over 66% of feces are liquid

- grade II: intermediate consistency between soft and liquid

- equal amounts of feces are soft and liquid

- grade III: over 66% of feces is soft

- firm enough to form a pile (no cylindrical appearance)

- grade IV: intermediate between firm and soft

- equal amounts of feces are firm and soft

- grade V: over 66% of feces in a defecation are firm

- cylindrical shape with little flattening

- CBC and chemistry before and 2 and 4 weeks after starting PEG3350

- palatability assessed by food intake and weight

- treatment stopped after 4 weeks

- cats monitored until stool consistency was normal for 2 defecations

Results

- grade I-III stool consistency achieved in all cats

- target consistency achieved in a median of 21.5 days

- median daily dose of powder to achieve target fecal grade: 3.0 ± 1.1 g

- median daily doses of the 6 cats to achieve target fecal grade

- 0.8, 1.5, 3.0, 3.0, 3.8 and 3.8 g

- dosage may be highly variable between cats

- diarrhea occasionally noted during treatment, 4 cats

- PEG3350 dosage decreased

- median time to return to normal consistency after stopping: 5.5 ± 3.4 days

- adverse event: no significant side effects noted in any cat

- sporadic vomiting, 1 cat during the treatment

- mild hyperkalemia, 3 cats at 5.6-6.0 mmol/l with reference at 3.9-5.5 mmol/l

- not associated with clinical signs in any of the cats

- food intake and body weight not significantly changed by PEG3350

“Our study demonstrated that PEG3350 with electrolytes is a safe and palatable oral laxative in healthy cats when used for 4 weeks. Potential side-effects include hyperkalemia; however, the changes we noted were not clinically or statistically significant.”

Article Tools:

Medline

Full Text on the Web

Email to me

Archives Highlights:

Factors Associated with Medication Noncompliance in Dogs in New Zealand.
Medication noncompliance was recorded for 47% (71/151) of owners. Increasing dog age was associated with better owner compliance. Forty-seven percent (71/151) of owners reported that "nobody" showed them how to administer the medication. One-third of dog owners (47/151) reported challenges in medicating their pets. The most common reason cited by clients reporting challenges was a resistant pet.

A public health campaign to increase awareness of the risk of dog bites in South Australia.
Over one third (36-37%) of dog owners and 25-29% of non-dog owners had been previously bitten by a dog, although most did not require medical attention. Approximately 70% of dog owners believed it was safe for strangers to approach their dog, 34-37% allowed children or other people to pat their dog without permission, and less than half separated their dog from visitors or delivery people. In contrast, few of the non-dog owners allowed their children to pat a dog without the owner's permission and only 2% allowed them to play with dogs without supervision.

Resolution of egg binding is possible in most client-owned parrots when multiple treatment strategies are considered.
Of the 150 events that had complete follow-up, 109 (72.7%) resulted in a successful outcome. A successful outcome was observed in 44 of 133 events (33.1%) that were initially managed medically without resorting to additional treatment strategies, in 31 events (86.1%) managed with mechanical assistance, in 20 events (60.6%) managed surgically, and in 12 events (85.7%) managed with ovocentesis.

Trust in veterinarians and association with vaccine information sources and vaccination status among dog and cat owners.
62.9% of dog and 61.2% of cat owners were classified as trusting their veterinarians. On average, dog owners consulted 2.50 sources about vaccine information; cat owners consulted 2.27 sources. Veterinarians were the most common primary sources of information for 85.4% of dog owners with high levels of trust, but only 62.6% of dog owners with lower levels. This was the case for 83.8% and 56.3% of cat owners.

Insights into breeding management and contraception in catteries - What we learned from an online survey.
Progestin pills (n = 235, 47.4 %) were most commonly administered in queens, followed by deslorelin implants (DSRI) (n = 53, 10.7 %). Regarding tomcats, the slight majority of breeders (n = 229, 53.3 %) did not use contraceptives, next common were DSRI (n = 141, 32.8 %). Within the study population, contraceptives were most popular in (Northern) Europe, while least common in Northern America.